PDF 8 MB - Consilium Medicum

29. Gershon ES, Hamovit J, Guroff JJ et al. A family study of schizoaffective,
bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiat
1982; 39 (10): 1157–67.
30. Ghaemi SN, Soldani F. Meta-analysis of observational studies: the case of
rapid-cycling bipolar disorder. Acta Psychiat Scand 2003; 108 (1): 1–3.
31. Glatzel J. Hearing of voices during cyclothymic-depressive syndrome. Wien
Z Nervenheilkd Grenzgeb 1973; 31 (1): 12–26.
32. Goldberg DP, Andrews G, Hobbs MJ. Where should bipolar disorder appear
in the meta-structure? Psychol Med 2009; 39: 2071–81.
33. Goodwin GM. (Consensus Group of the British Association for Psychopharmacology):
Evidence-based guidelines for treating bipolar disorder: recommendations
from the British Association for Psychopharmacology. J Psychopharmacol
2003; 17: 149–73.
34. Goodwin G, Sachs G. Bipolar disorder. Oxford 2004.
35. Griesinger W. Mental pathology and theraprutics. Ed. J.Rutherford. NY
1855.
36. Ha TH, Ha K, Kim JH et al. Regional brain gray matter abnormalities in patients
with bipolar II disorder: a comparison study with bipolar I patients and
healthy controls. Neurosci Lett 2009; 456: 4–48.
37. Hirschfeld RM. Practice guideline for the treatment of patients with bipolar
disorder. 2nd ed. American Psychiatric Association 2005.
38. Hirschfeld RM, Holzer C, Calabrese JR et al. Validity of the mood disorder
questionnaire: a general population study. Am J Psychiat 2003; 160: 178–80.
39. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders
in the US population: reanalysis of the ECA database taking into account
subthreshold cases. J Affect Disord 2003; 73: 123–31.
40. Janicak PG, Keck PE Jr, Davis JM et al. A double-blind, randomized,
prospective evaluation of the efficacy and safety of risperidone versus
haloperidol in the treatment of schizoaffective disorder. J Clin Psychopharmacol
2001; 21: 360–8.
41. Kaplan HI, Sadock BJ. Pocket handbook of clinical psychiatry. Williams &
Wilkins 1996.
42. Klerman GL. The spectrum of mania. Compr Psychiat 1981; 22 (1):
11–20.
43. Kraepelin E. Manic-Depressive illness and paranoia. R.Barclay (trans) in
G.Robertson. Edinburgh. E&S Livingstone 1921.
44. Leonhard K. Auftelling der endogenen psychosen. Berlin 1957.
45. Lynch TR, Trost WT, Salsman N et al. Dialectical behavior therapy for borderline
personality disorder. Ann Rev Clin Psychol 2007; 3: 181–205.
46. Maj M, Pirozzi R, Magliano L et al. Agitated «unipolar» major depression:
prevalence, phenomenology, and outcome. J Clin Psychiat 2006; 67: 712–9.
47. Manning JS. Difficult-to-treat depressions: a primary care perspective.
J Clin Psychiat 2003; 64: 24–31.
48. Manning JS, Haykal RF, Akiskal HS. The role of bipolarity in depression in
the family practice setting. Psychiatr Clin North Am 1999; 22: 689–703.
49. McElroy SL et al. A 52-week, open-label continuation study of lamotrigine
in the treatment of bipolar depression. J Clin Psychiat 2004; 2: 204–10.
50. McElroy SL, Frye MA, Hellemann G et al. Prevalence and correlates of eating
disorders in 875 patients with bipolar disorder. J Affect Disord 2011; 128:
191–8.
51. McElroy SL, Keck PE Jr, Strakowski SM. An overview of the treatment of
schizoaffective disorder. J Clin Psychiat 1999; 5: 16–21.
52. McGuffin P, Rijsdijk F, Andrew M et al. The heritability of bipolar affective
disorder and genetic relationship to unipolar depression. Arch Gen Psychiat
2003; 60: 497–502.
53. Mercer D, Douglass AB, Links PS. Meta-analyses of mood stabilizers, antidepressants
and antipsychotics in the treatment of borderline personality disorder:
effectiveness for depression and anger symptoms. J Pers Disord 2009;
23: 156–74.
54. Merikangas KR, Akiskal HS, Angst J et al. Lifetime and 12-month prevalence
of bipolar spectrum disorder in the National Comorbidity Survey replication.
Arch Gen Psychiat 2007; 64: 543–52.
55. Montgomery SA et al. Pharmacotherapy of depression and mixed states in
bipolar disorder. J of affective disorders 2000; 59 (1): 39–56.
56. Narrow WE, Rae DS, Robins LN et al. Revised prevalence estimates of mental
disorders in the United States: using a clinical significance criterion to reconcile
2 surveys’ estimates. Arch Gen Psychiat 2002; 59: 115–23.
57. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nature
Neurosci 2010; 13: 1161–9.
П С И Х И А Т Р И Я И П С И Х О Ф А Р М А К О Т Е Р А П И Я Т о м 1 4 № 2
ОКНО В МИР
58. Nurnberger JI Jr. A simulated genetic structure for bipolar illness. Am J Med
Genet B Neuropsychiat Genet 2008; 147 (B): 952–6.
59. Nurnberger JI Jr, Berrettini W. Psychiatric genetics. In: M.Ebert, P.Loosen,
B.Nurcombe et al (eds). Current diagnosis and treatment. 2nd ed. NY: Mc-
Graw Hill. Psychiat 2008; p. 15–34.
60. Owen MJ, Craddock N, Jablensky A. The genetic deconstruction of psychosis.
Schizophr Bull 2007; 33: 905–11.
61. Parens E, Johnston J. Controversies concerning the diagnosis and treatment
of bipolar disorder in children. Child and Adolescent Psychiat and Mental
Health 2010; 4: 9.
62. Paris J. The bipolar spectrum: a critical perspective. Harv Rev Psychiat
2009; 17: 206–13.
63. Parker GB, Malhi GS, Crawford JG et al. Identifying «paradigm failures»
contributing to treatment-resistant depression. J Affect Disord 2005; 87:
185–91.
64. Patten SB, Paris J. The bipolar spectrum – a bridge too far? Can J Psychiat
2008; 53: 762–8.
65. Perlis RH, Uher R, Ostacher M et al. Association between bipolar spectrum
features and treatment outcomes in outpatients with major depressive disorder.
Arch Gen Psychiat 2011; 68 (4): 351–60.
66. Perugi G, Toni C, Travierso MC et al. The role of cyclothymia in atypical depression:
toward a data-based reconceptualization of the borderline-bipolar
II connection. J Affect Disord 2003; 73: 87–98.
67. Perugi G, Akiskal HS. The soft bipolar spectrum redefined: focus on the cyclothymic,
anxious-sensitive, impulse-dyscontrol, and binge-eating connection
in bipolar II and related conditions. Psychiatr Clin North Am 2002; 25:
713–37.
68. Phelps J, Angst J, Katzow J et al. Validity and utility of bipolar spectrum
models. Bipolar Disord 2008; 10: 179–93.
69. Pinel P. A Treatise on Insanity. Cadell and Davies. London 1806.
70. Prakash O, Kumar CN, Shivakumar PT et al. Clinical presentation of mania
compared with depression: data from a geriatric clinic in India. Int Psychogeriat
2009; 21: 764–7.
71. Ruggero CJ, Zimmerman M, Chelminski I et al. Borderline personality disorder
and the misdiagnosis of bipolar disorder. J Psychiatr Res 2010; 44:
405–8.
72. Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant
treatment for bipolar depression. N Engl J Med 2007; 356:
1711–22.
73. Sato T, Bottlender R, Schröter A et al. Frequency of manic symptoms during
a depressive episode and unipolar «depressive mixed state» as bipolar spectrum.
Acta Psychiat Scand 2003; 107: 268–74.
74. Simonsen C, Sundet K, Vaskinn A et al. Neurocognitive profiles in bipolar I
and bipolar II disorder: differences in pattern and magnitude of dysfunction.
Bipolar Disord 2008; 10: 245–55.
75. Smith DJ, Muir WJ, Blackwood DH. Is borderline personality disorder part
of the bipolar spectrum? Harv Rev Psychiat 2004; 12: 133–9.
76. Sole B, Martinez-Aran A, Torrent C et al. Are bipolar II patients cognitively
impaired: a systematic review. Psychol Med 2011; 41 (9): 1791–803.
77. Strakowski SM, Fleck DE, Maj M. Broadening the diagnosis of bipolar disorder:
benefits vs risks. World Psychiat 2011; 10: 181–7.
78. Suppes T, Dennehy EB et al. The Texas implementation of medication algorithms:
update to the algorithms for treatment of bipolar I disorder. J Clin
Psychiat 2005; 66 (7): 870–86.
79. Swann AC, Bowden CL et al. Depression during mania. Arch Gen Psychiat
1997; 54: 37–42.
80. Taylor Tavares JV, Clark L, Cannon DM et al. Distinct profiles of neurocognitive
function in unmedicated unipolar depression and bipolar II disorder.
Biol Psychiat 2007; 62: 917–24.
81. Zimmermann P, Brückl T, Nocon A et al. Heterogeneity of DSM-IV major
depressive disorder as a consequence of subthreshold bipolarity. Arch Gen
Psychiat 2009; 66: 1341–52.
82. Zimmerman M, Ruggero CJ, Chelminski I et al. Clinical characteristics of
depressed outpatients previously overdiagnosed with bipolar disorder. Compr
Psychiat 2010; 51: 99–105.
83. Zimmerman M, Ruggero CJ, Chelminski I et al. Psychiatric diagnoses in patients
previously overdiagnosed with bipolar disorder. J Clin Psychiat 2010;
71: 26–31.
Сведения об авторе
Медведев Владимир Эрнстович – канд. мед. наук, доц. каф. психиатрии, психотерапии и психосоматической патологии
ФПКМР РУДН. E-mail: melkorcard@mail.ru
Поправка
В №1 журнала за 2012 год в статье «Болезнь Альцгеймера: на стыке биологического и психосоциального (опыт организации
работы с больными деменцией и ухаживающими за ними лицами)» по вине верстальщика были указаны неправильные
сведения об авторах. Адрес для корреспонденции: v.merkel@pb10.ru; r.cheremin@pb10.ru.
Кроме того, по вине научного редактора в тексте допущены ошибки: вместо «Мемантин ТТС» следует читать «ривастигмин
ТТС».
Мы приносим авторам и читателям свои извинения.
Редакция
72